Could the mosaic pattern of chromosomal abnormality predict overall survival of patients with myelodysplastic syndrome?


UYANIK M. Ş., DEMİR A. M., KURT İ., MADEN M., ÖZ PUYAN F., GÜRKAN H., ...Daha Fazla

Hematology/oncology and stem cell therapy, cilt.9, sa.2, ss.41-7, 2016 (Scopus) identifier identifier